tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BVXV

BiondVax changes name to Scinai Immunotherapeutics
The FlyBiondVax changes name to Scinai Immunotherapeutics
11M ago
BVXV
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
PremiumPress Releases
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
11M ago
BVXV
BiondVax files $150M mixed securities shelf
PremiumThe Fly
BiondVax files $150M mixed securities shelf
11M ago
BVXV
BiondVax Reports Second Quarter Financial Results and Provides Business Update
PremiumPress Releases
BiondVax Reports Second Quarter Financial Results and Provides Business Update
12M ago
BVXV
BiondVax reports Q2 EPS 0c vs 0c last year
PremiumThe Fly
BiondVax reports Q2 EPS 0c vs 0c last year
12M ago
BVXV
Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules
PremiumPress ReleasesNasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules
12M ago
BVXV
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
BLPH
BVXV
BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business Update
PremiumPress Releases
BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business Update
1y ago
BVXV
BiondVax to Present at BIO-Europe Spring
PremiumPress Releases
BiondVax to Present at BIO-Europe Spring
1y ago
BVXV
BiondVax Presenting at BIO CEO & Investor Conference
PremiumPress Releases
BiondVax Presenting at BIO CEO & Investor Conference
1y ago
BVXV
BiondVax’s inhaled NanoAb for COVID-19 shows efficacy in preclinical study
PremiumThe Fly
BiondVax’s inhaled NanoAb for COVID-19 shows efficacy in preclinical study
2y ago
BVXV
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
PremiumPress Releases
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
2y ago
BVXV
BiondVax announces results of preclinical study of inhaled COVID-19 therapy
PremiumThe FlyBiondVax announces results of preclinical study of inhaled COVID-19 therapy
2y ago
BVXV
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
PremiumPress Releases
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
2y ago
BVXV
BiondVax CEO Issues Letter to Shareholders
PremiumPress Releases
BiondVax CEO Issues Letter to Shareholders
2y ago
BVXV
BiondVax CEO says set the stage in 2022 for ‘highly successful’ 2023
PremiumThe Fly
BiondVax CEO says set the stage in 2022 for ‘highly successful’ 2023
2y ago
BVXV
BiondVax Announces Closing of $8 Million Underwritten Public Offering
PremiumPress Releases
BiondVax Announces Closing of $8 Million Underwritten Public Offering
2y ago
BVXV
BiondVax announces pricing of $8M underwritten public offering
PremiumThe Fly
BiondVax announces pricing of $8M underwritten public offering
2y ago
BVXV
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
PremiumPress Releases
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
2y ago
BVXV
BiondVax regains Nasdaq compliance
PremiumThe FlyBiondVax regains Nasdaq compliance
2y ago
BVXV
BiondVax Regains Nasdaq Compliance
PremiumPress Releases
BiondVax Regains Nasdaq Compliance
2y ago
BVXV
IBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd.
PremiumPress Releases
IBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd.
2y ago
BVXV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >